The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia
- 1 June 2003
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 53 (6) , 1008-1012
- https://doi.org/10.1203/01.pdr.0000064580.23308.cb
Abstract
Children with familial hypercholesterolemia (FH) exhibit substantial variance of LDL cholesterol. In previous studies, family members of children with FH were included, which may have influenced results. To avoid such bias, we studied phenotype in 450 unrelated children with FH and in 154 affected sib-pairs. In known families with classical FH, diagnosis was based on plasma LDL cholesterol above the age- and gender-specific 95th percentile. Girls had 0.47 ± 0.15 mmol/L higher LDL cholesterol, compared with boys (p = 0.002). Also in girls, HDL cholesterol increased by 0.07 ± 0.03 mmol/L per 5 y (pfor trend = 0.005); this age effect was not observed in boys. The distribution of apolipoprotein (apo) E genotypes was not significantly different between probands, their paired affected siblings, or a Dutch control population. Carriers with or without one ε4 allele had similar LDL and HDL cholesterol levels. Within the affected sib-pairs, the ε4 allele explained 72.4% of the variance of HDL cholesterol levels (−0.15 mmol/L, 95% confidence interval −0.24 to −0.05, p = 0.003). The effect of apoE4 on HDL cholesterol differed with an analysis based on probands or on affected sib-pairs. The affected sib-pair model used adjustment for shared environment, type of LDL receptor gene mutation, and a proportion of additional genetic factors and may, therefore, be more accurate in estimating effects of risk factors on complex traits. We conclude that the ε4 allele was associated with lower HDL cholesterol levels in an affected sib-pair analysis, which strongly suggests that apoE4 influences HDL cholesterol levels in FH children. Moreover, the strong association suggests that apoE4 carries an additional disadvantage for FH children.Keywords
This publication has 32 references indexed in Scilit:
- Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: The Bogalusa Heart StudyAtherosclerosis, 1999
- Determinants of Lipid Levels Among Children With Heterozygous Familial Hypercholesterolemia in NorwayArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapyJournal of Internal Medicine, 1993
- The role of apolipoprotein E genetic variants in lipoprotein disordersJournal of Internal Medicine, 1992
- Association of hypercholesterolemia and apolipoprotein E4 in school childrenClinical Genetics, 1990
- Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemiaAtherosclerosis, 1990
- Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E‐2/2 phenotypeEuropean Journal of Clinical Investigation, 1990
- Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levelsHuman Genetics, 1988
- Reciprocal effects of apolipoprotein E alleles (ε2 AND ε4) on plasma lipid levels in normolipidemic subjectsClinical Genetics, 1986
- Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early AtherosclerosisNew England Journal of Medicine, 1986